chr14-21001287-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014579.4(SLC39A2):c.638G>A(p.Arg213Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000379 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014579.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC39A2 | ENST00000298681.5 | c.638G>A | p.Arg213Gln | missense_variant | 4/4 | 1 | NM_014579.4 | ENSP00000298681.4 | ||
SLC39A2 | ENST00000554422.5 | c.*375G>A | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000452568.1 | ||||
ENSG00000258471 | ENST00000647921.1 | n.398-1457C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000286 AC: 72AN: 251392Hom.: 0 AF XY: 0.000213 AC XY: 29AN XY: 135868
GnomAD4 exome AF: 0.000378 AC: 552AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.000342 AC XY: 249AN XY: 727246
GnomAD4 genome AF: 0.000388 AC: 59AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000417 AC XY: 31AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.638G>A (p.R213Q) alteration is located in exon 4 (coding exon 4) of the SLC39A2 gene. This alteration results from a G to A substitution at nucleotide position 638, causing the arginine (R) at amino acid position 213 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at